-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
9 min read
Latest News
-
Closing the care gap: new guidelines for HD care
6 min read
Closing the care gap: new guidelines to help every Huntington's disease patient get great care
-
Stem-cell neurons make the right connections
7 min read
Replacing neurons in mice with stem cells works much better than expected, suggesting that replacement therapy might
-
2012 Therapeutics Conference: a retrospective
19 min read
HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference
-
Mutant yeast highlights crucial CAG-reading protein
5 min read
A new job for a DNA-reading protein called SPT4 – controlling the balance of mutant and healthy huntingtin protein
-
HD Therapeutics Conference 2012 Updates: Day 3
6 min read
Day 3 of our coverage of the Huntington's Disease Therapeutics Conference
-
HD Therapeutics Conference 2012 Updates: Day 2
4 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-
HD Therapeutics Conference 2012 Updates: Day 1
5 min read
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-
Coming soon: HD Therapeutics Conference 2012
2 min read
Huntington's Disease Therapeutics Conference starts next week. Twitter follow @HDBuzzfeed for live updates!
-
New analysis suggests 'small' CAG length doesn't matter after all
7 min read
Size isn't everything: new research suggests that only a person's big CAG count, not the small one, affects HD onset
-
Special 'brain fat' injection helps HD mice
5 min read
Directly injecting the brains of HD mice with a good type of fat called ganglioside GM1 provides dramatic benefit
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
